Atea Pharmaceuticals Inc
NASDAQ: avir
$7.09
USD
+$0.29
+4.27%
Prev Close
$6.80
Today's Open
$6.83
Volume
410.85K
Market Cap
589.2M
Day Range
52W Range
Overview
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapies for patients suffering from viral infections. The company is headquartered in Boston, Massachusetts.
Read moreCurrent Price
15 min delay
Catalysts
There are currently no catalysts for AVIR. If there's something you'd like to see, feel free to reach out to us on discord.
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)
Insufficient Data
Ratios
Valuation Ratios
EPS (TTM)
0.312
P/E Ratio
21.79
Price to Sales
2.719
Price to Book
0.935
Profit Ratios
Profit Margin
11.90%
EBITDA Margin
18.22%
Net Profit Margin
5.11%
ROA
4.96%
Total Revenue
$207.82M
Net Profit
$10.61M
EV to EBITDA
3.577
EV to Revenue
0.652